As part of our ongoing efforts to promote child health and early intervention, our team undertook the development of an informative and engaging pamphlet focused on Georgia’s National Newborn Screening (NBS) Program. The aim of this pamphlet is to raise awareness and ensure that caregivers understand the life-saving importance of early screening for genetic and metabolic conditions.

Through collaborative research and design, the team compiled key data, including the facts about Georgia, with nearly 100% of them screened under the national program. The pamphlet traces the program’s development—from the initial inclusion of PKU and Congenital Hypothyroidism in 2003, to the addition of Cystic Fibrosis in 2012, along with galactosemia, adrenogenital syndrome, biotinidase deficiency, hyperphenylalaninemia, and hearing impairment.

We also incorporated recent findings on the high prevalence of the 1677delTA (Δ) mutation in Georgian CF patients, underlining the importance of localized genetic awareness.
The content was designed to be caregiver-friendly, emphasizing how early detection, timely intervention, and ongoing support can dramatically improve health outcomes.

By translating clinical facts into accessible information, we move closer to a future where no newborn is left undiagnosed or untreated.

We also collaborated with a Georgian public health association to ensure accurate translation in order for the pamphlet to be more useful for the locals.